• When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study 

      de Rocafiguera, Claudi; Belsa, Blanca; Font-Bardia, Mercè; Puigjaner, Cristina; Serra, Eduard; Cuartero Albesa, Ana María; Puig de la Bellacasa, Raimon; Borrell, Jose I. (Pharmaceuticals. 2024;17(3):284, 2024-02-22)
      The impact of the crystalline or amorphous structure of a solid on the solubility and pharmacokinetic properties of a drug candidate is always considered by the pharmaceutical industry during the ...